Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$3.38 - $4.22 $3,619 - $4,519
-1,071 Reduced 4.21%
24,362 $89,000
Q3 2022

Nov 14, 2022

BUY
$3.43 - $5.83 $1,715 - $2,915
500 Added 2.01%
25,433 $92,000
Q2 2022

Aug 12, 2022

BUY
$4.41 - $5.69 $1,102 - $1,422
250 Added 1.01%
24,933 $132,000
Q4 2020

Feb 12, 2021

BUY
$5.25 - $8.56 $129,585 - $211,286
24,683 New
24,683 $171,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $331M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Creative One Wealth, LLC Portfolio

Follow Creative One Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative One Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Creative One Wealth, LLC with notifications on news.